NJ hospital survey showed hydroxychloroquine might help keep certain patients from being hospitalized.

Rutgers researchers are leading a clinical trial using a three-drug combination to assess if the medications, when taken together, can shorten the duration of COVID-19. ...

The Newark-based medical center launched a trial of Remdesivir this month for 16 severely infected patients. It says six improved, five remain on ventilators and ...

Holy Name Medical Center's CEO Michael Maron was asymptomatic and unknowingly spread the virus to his family. His staff urged him to get tested. The ...